Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma
- PMID: 25746630
- DOI: 10.1136/thoraxjnl-2014-206067
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma
Abstract
Background: Steroid-insensitive endotypes of asthma are an important clinical problem and effective therapies are required. They are associated with bacterial infection and non-eosinophilic inflammatory responses in the asthmatic lung. Macrolide therapy is effective in steroid-insensitive endotypes, such as non-eosinophilic asthma. However, whether the effects of macrolides are due to antimicrobial or anti-inflammatory mechanisms is not known.
Objective: To determine and assess the efficacy of macrolide (ie, clarithromycin) and non-macrolide (ie, amoxicillin) antibiotic treatments in experimental models of infection-induced, severe, steroid-insensitive neutrophilic allergic airways disease (SSIAAD), compared with steroid-sensitive AAD and to delineate the antimicrobial and anti-inflammatory effects of macrolide therapy.
Methods: We developed and used novel mouse models of Chlamydia and Haemophilus lung infection-induced SSIAAD. We used these models to investigate the effects of clarithromycin and amoxicillin treatment on immune responses and airways hyper-responsiveness (AHR) in Ova-induced, T helper lymphocyte (Th) 2 -associated steroid-sensitive AAD and infection-induced Th1/Th17-associated SSIAAD compared with dexamethasone treatment.
Results: Clarithromycin and amoxicillin had similar antimicrobial effects on infection. Amoxicillin did attenuate some features, but did not broadly suppress either form of AAD. It did restore steroid sensitivity in SSIAAD by reducing infection. In contrast, clarithromycin alone widely suppressed inflammation and AHR in both steroid-sensitive AAD and SSIAAD. This occurred through reductions in Th2 responses that drive steroid-sensitive eosinophilic AAD and tumour necrosis factor α and interleukin 17 responses that induce SSIAAD.
Conclusions: Macrolides have broad anti-inflammatory effects in AAD that are likely independent of their antimicrobial effects. The specific responses that are suppressed are dependent upon the responses that dominate during AAD.
Keywords: Allergic lung disease; Asthma; Bacterial Infection; Respiratory Infection.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Comment in
-
Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?Thorax. 2015 May;70(5):401-3. doi: 10.1136/thoraxjnl-2015-207080. Thorax. 2015. PMID: 25870311 No abstract available.
Similar articles
-
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma.Thorax. 2012 Jul;67(7):588-99. doi: 10.1136/thoraxjnl-2011-200160. Epub 2012 Mar 3. Thorax. 2012. PMID: 22387445
-
Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease.PLoS Pathog. 2011 Oct;7(10):e1002244. doi: 10.1371/journal.ppat.1002244. Epub 2011 Oct 6. PLoS Pathog. 2011. PMID: 21998577 Free PMC article.
-
MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2.J Allergy Clin Immunol. 2017 Feb;139(2):519-532. doi: 10.1016/j.jaci.2016.04.038. Epub 2016 Jun 10. J Allergy Clin Immunol. 2017. PMID: 27448447
-
Macrolides in the treatment of asthma.Curr Opin Pulm Med. 2012 Jan;18(1):76-84. doi: 10.1097/MCP.0b013e32834daff8. Curr Opin Pulm Med. 2012. PMID: 22112996 Review.
-
Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.Paediatr Drugs. 2003;5 Suppl 1:25-33. Paediatr Drugs. 2003. PMID: 14632103 Review.
Cited by
-
Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease.Clin Transl Immunology. 2019 Oct 28;8(10):e01084. doi: 10.1002/cti2.1084. eCollection 2019. Clin Transl Immunology. 2019. PMID: 31921419 Free PMC article.
-
4-Octyl Itaconate Alleviates Airway Eosinophilic Inflammation by Suppressing Chemokines and Eosinophil Development.J Immunol. 2024 Jan 1;212(1):13-23. doi: 10.4049/jimmunol.2300155. J Immunol. 2024. PMID: 37991425 Free PMC article.
-
Cellular mechanisms underlying steroid-resistant asthma.Eur Respir Rev. 2019 Oct 21;28(153):190096. doi: 10.1183/16000617.0096-2019. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31636089 Free PMC article. Review.
-
Asthma-COPD overlap: current understanding and the utility of experimental models.Eur Respir Rev. 2021 Feb 16;30(159):190185. doi: 10.1183/16000617.0185-2019. Print 2021 Mar 31. Eur Respir Rev. 2021. PMID: 33597123 Free PMC article. Review.
-
Individualized Treatment for Allergic Rhinitis.Allergy Asthma Immunol Res. 2017 Sep;9(5):383-385. doi: 10.4168/aair.2017.9.5.383. Allergy Asthma Immunol Res. 2017. PMID: 28677350 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical